PharmaShots | Incisive News in 3 Shots

Subscribe Now

New Antibody Drug

CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications

CStone Signs a License Agreement with LegoChem for LCB71 to Treat Multiple Cancer Indications

October 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us